Scientific Review and Monitoring Committee

How do I know if my study needs to be submitted to the SRMC?

All studies of cancer relevant studies that are conducted on the UF Health Gainesville campus or UFPTI must be reviewed by the SRMC.

The University of Florida defines a “cancer relevant” study as one that;

  • Specifies enrolling patients with a known or suspected diagnosis of cancer as part of the eligibility criteria; or
  • Includes research endpoints related to cancer, associated symptoms or established cancer risk factors (including smoking and tobacco-associated studies, surveys, hepatitis or HPV vaccines, etc.); or
  • The local PI plans to exclusively enroll current, former or potential cancer patients into the study

It is difficult to list every possible scenario in which a study would be considered cancer-relevant, in general, this means that it involves cancer patients, uses data, tissue, or blood specimens from cancer patients, or will lead to findings that may be significant to cancer patients. If an Investigator is unsure if a study meets cancer-relevant criteria, please contact the SRMC Coordinator to determine if the study must be submitted for SRMC review and approval.

Who can I speak to regarding the SRMC or for more information?

For information related to the SRMC please email SRMC Coordinator or the Associate Director, Alison Ivey, at or 352.294.8567

You may also review the SRMC Policies and Procedures Manual ,  SRMC Policy Existing Studies and the UFHCC IIT Policy Document. IIT Memo 2018-March.

The Clinical Trials Office core services are available to individuals who are Cancer Center members. In order to become a member of the UF Health Cancer Center, please visit the Membership Policy and Application site. For further questions about membership with the UFHCC, please contact Wendy Malorzo or call 352.273.8294.